Clinical Bioequivalence Study on Two Paracetamol Tablet Formulations
The objective of the study is to compare the bioavailability of a generic product of paracetamol (immediate-release) with that of a reference product when administered to healthy volunteers under fasting condition. The test product is Fortolin Tab 500mg manufactured by Fortune Pharmacal Co. Ltd., and the reference product is Panadol Caplet 500mg manufactured by GlaxoSmithKline (Dungarvan) Ltd. The plasma pharmacokinetic data of paracetamol obtained from two formulations will be used to evaluate the interchangeability of the products.
100 Clinical Results associated with Fortune Pharmacal Co. Ltd.
0 Patents (Medical) associated with Fortune Pharmacal Co. Ltd.
100 Deals associated with Fortune Pharmacal Co. Ltd.
100 Translational Medicine associated with Fortune Pharmacal Co. Ltd.